Log In
BCIQ
Print this Print this
 

B cell lymphoma 2 (BCL-2) (BCL2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting B cell lymphoma 2 (BCL-2) (BCL2)

BCIQ
Print ChartPrint this
1 - Cancer 1 - Cancer 4 - Cancer 2 - Cancer 4 - Cancer 1 - Autoimmune 3 - Cancer
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Autoimmune

-

1

-

-

-

-

Cancer

3

4

2

4

1

1




 Products Targeting B cell lymphoma 2 (BCL-2) (BCL2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$536.1M

$226.0M

$300.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today